Skip to main content
Journal cover image

Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation

Publication ,  Conference
Alexander, J; Andersson, U; Lopes, RD; Hijazi, Z; Hohnloser, SH; Ezekowitz, J; Halvorsen, S; Hanna, M; Granger, CB; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2015

Duke Scholars

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2015

Volume

36

Start / End Page

345 / 345

Location

London, ENGLAND

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alexander, J., Andersson, U., Lopes, R. D., Hijazi, Z., Hohnloser, S. H., Ezekowitz, J., … Wallentin, L. (2015). Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. In EUROPEAN HEART JOURNAL (Vol. 36, pp. 345–345). London, ENGLAND: OXFORD UNIV PRESS.
Alexander, J., U. Andersson, R. D. Lopes, Z. Hijazi, S. H. Hohnloser, J. Ezekowitz, S. Halvorsen, M. Hanna, C. B. Granger, and L. Wallentin. “Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation.” In EUROPEAN HEART JOURNAL, 36:345–345. OXFORD UNIV PRESS, 2015.
Alexander J, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz J, et al. Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 345–345.
Alexander J, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz J, Halvorsen S, Hanna M, Granger CB, Wallentin L. Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 345–345.
Journal cover image

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2015

Volume

36

Start / End Page

345 / 345

Location

London, ENGLAND

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology